Paracoccidioidomycosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
**superficial node enlargement
**superficial node enlargement
**deep lymph node enlargement
**deep lymph node enlargement
*The symptoms of PMC chronic usually develop in the third decade of life, eventhough the infection can be acquired in the first decade of life <ref name=?>Vargas J, Vargas R. Paracoccidiodomicosis. ''Rev. enferm. infecc. trop.''2009(1):49-56</ref>.... Start with symptoms such as ___. The symptoms of (disease name) typically develop ___ years after exposure to ___. Without treatment, the patient will develop symptoms of ___, which will/ may eventually lead to ___.
*The symptoms of PMC chronic usually develop in the third decade of life, eventhough the infection can be acquired in the first decade of life <ref name=a>Vargas J, Vargas R. Paracoccidiodomicosis. ''Rev. enferm. infecc. trop.''2009(1):49-56</ref>.... Start with symptoms such as ___. The symptoms of (disease name) typically develop ___ years after exposure to ___. Without treatment, the patient will develop symptoms of ___, which will/ may eventually lead to ___.
===Infection===
===Infection===
*The infection can be adquired in the first decade of life. PMC infection has no manifested symptoms. <ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
*The infection can be adquired in the first decade of life. PMC infection has no manifested symptoms. <ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
Line 16: Line 16:
===Chronic===
===Chronic===
==Complications==
==Complications==
Complications that can develop as a result of PMC are:
Paracoccidioidomycosis develops sequelae frequently:
*"Worsening of chronic obstructive pulmonary disease (COPD)
*Chronic obstructive pulmonary disease (COPD)
*Adrenal gland dysfunction (15-50%)
*Pulmonary fibrosis
*dysphonia or laryngeal obstruction, or a combination of the two
*Adrenal gland insufficiency
*reduced mouth opening
*Superior airway obstruccion (dysphonia and laryngeal lesions)
*epilepsy or hydrocephalur, or both (6-25%)" <ref name=?> Wanke B, Aidê M. Chapter 6 - Paracoccidioidomycosis. ''J. bras. pneumol.'' 2009; 35(12):1245-1249 </ref>
*Difficulty for mouth opening
*Seizures
*Motor deficiency <ref name=b> Wanke B, Aidê M. Chapter 6 - Paracoccidioidomycosis. ''J. bras. pneumol.'' 2009; 35(12):1245-1249 </ref> <ref name=c> Francesconi F, da Silva MT, Costa RL, et al. Long-term outcome of neuroparacoccidioidomycosis treatment. ''Rev Soc Bras Med Trop.'' 2011;44(1):22-25</ref>


==Prognosis==
==Prognosis==

Revision as of 18:20, 18 January 2016

Paracoccidioidomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paracoccidioidomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Paracoccidioidomycosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paracoccidioidomycosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paracoccidioidomycosis natural history, complications and prognosis

CDC on Paracoccidioidomycosis natural history, complications and prognosis

Paracoccidioidomycosis natural history, complications and prognosis in the news

Blogs on Paracoccidioidomycosis natural history, complications and prognosis

Directions to Hospitals Treating Paracoccidioidomycosis

Risk calculators and risk factors for Paracoccidioidomycosis natural history, complications and prognosis

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Natural History

  • The symptoms of acute/subacute PMC is usually develop in children and young adults, under 35 years. Start with inespecific symptoms such as:
    • superficial node enlargement
    • deep lymph node enlargement
  • The symptoms of PMC chronic usually develop in the third decade of life, eventhough the infection can be acquired in the first decade of life [1].... Start with symptoms such as ___. The symptoms of (disease name) typically develop ___ years after exposure to ___. Without treatment, the patient will develop symptoms of ___, which will/ may eventually lead to ___.

Infection

  • The infection can be adquired in the first decade of life. PMC infection has no manifested symptoms. [2]

Acute/subacute

Chronic

Complications

Paracoccidioidomycosis develops sequelae frequently:

  • Chronic obstructive pulmonary disease (COPD)
  • Pulmonary fibrosis
  • Adrenal gland insufficiency
  • Superior airway obstruccion (dysphonia and laryngeal lesions)
  • Difficulty for mouth opening
  • Seizures
  • Motor deficiency [3] [4]

Prognosis

References

  1. Vargas J, Vargas R. Paracoccidiodomicosis. Rev. enferm. infecc. trop.2009(1):49-56
  2. Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.
  3. Wanke B, Aidê M. Chapter 6 - Paracoccidioidomycosis. J. bras. pneumol. 2009; 35(12):1245-1249
  4. Francesconi F, da Silva MT, Costa RL, et al. Long-term outcome of neuroparacoccidioidomycosis treatment. Rev Soc Bras Med Trop. 2011;44(1):22-25